Literature DB >> 22491772

Epidemiology of and diagnostic strategies for toxoplasmosis.

Florence Robert-Gangneux1, Marie-Laure Dardé.   

Abstract

The apicomplexan parasite Toxoplasma gondii was discovered a little over 100 years ago, but knowledge of its biological life cycle and its medical importance has grown in the last 40 years. This obligate intracellular parasite was identified early as a pathogen responsible for congenital infection, but its clinical expression and the importance of reactivations of infections in immunocompromised patients were recognized later, in the era of organ transplantation and HIV infection. Recent knowledge of host cell-parasite interactions and of parasite virulence has brought new insights into the comprehension of the pathophysiology of infection. In this review, we focus on epidemiological and diagnostic aspects, putting them in perspective with current knowledge of parasite genotypes. In particular, we provide critical information on diagnostic methods according to the patient's background and discuss the implementation of screening tools for congenital toxoplasmosis according to health policies.

Entities:  

Mesh:

Year:  2012        PMID: 22491772      PMCID: PMC3346298          DOI: 10.1128/CMR.05013-11

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  334 in total

1.  Commentary: Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out.

Authors:  P Thulliez
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

2.  Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG).

Authors:  L Putignani; L Mancinelli; F Del Chierico; D Menichella; D Adlerstein; M C Angelici; M Marangi; F Berrilli; M Caffara; D A Frangipane di Regalbono; A Giangaspero
Journal:  Exp Parasitol       Date:  2010-10-25       Impact factor: 2.011

Review 3.  Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review.

Authors:  Laurence Delhaes; Daniel Ajzenberg; Bérangère Sicot; Philippe Bourgeot; Marie-Laure Dardé; Eduardo Dei-Cas; Véronique Houfflin-Debarge
Journal:  Prenat Diagn       Date:  2010-09       Impact factor: 3.050

4.  Detection of Toxoplasma gondii oocysts in environmental samples from public schools.

Authors:  Thaís Rabelo dos Santos; Cáris Maroni Nunes; Maria Cecília Rui Luvizotto; Anderson Barbosa de Moura; Welber Daniel Zanetti Lopes; Alvimar José da Costa; Katia Denise Saraiva Bresciani
Journal:  Vet Parasitol       Date:  2010-03-03       Impact factor: 2.738

5.  Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.

Authors:  M H Bessières; A Berrebi; M Rolland; M C Bloom; C Roques; S Cassaing; C Courjault; J P Séguéla
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-01       Impact factor: 2.435

6.  Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.

Authors:  Luuk Gras; Martine Wallon; Arnold Pollak; Mario Cortina-Borja; Birgitta Evengard; Michael Hayde; Eskild Petersen; Ruth Gilbert
Journal:  Acta Paediatr       Date:  2005-12       Impact factor: 2.299

7.  Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.

Authors:  Guillaume Béraud; Sandrine Pierre-François; Adeline Foltzer; Sylvie Abel; Bernard Liautaud; Didier Smadja; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

8.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.

Authors:  J L Burg; C M Grover; P Pouletty; J C Boothroyd
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

9.  Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.

Authors:  F Sordet; Y Aumjaud; H Fessi; F Derouin
Journal:  Parasite       Date:  1998-09       Impact factor: 3.000

10.  Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.

Authors:  Lílian Maria Garcia Bahia-Oliveira; Jeffrey L Jones; Juliana Azevedo-Silva; Cristiane C F Alves; Fernando Oréfice; David G Addiss
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more
  416 in total

1.  Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites.

Authors:  P Holland Alday; Erin V McConnell; Jan M Boitz Zarella; Rozalia A Dodean; Papireddy Kancharla; Jane X Kelly; J Stone Doggett
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

2.  First report of typical Brazilian Toxoplasma gondii genotypes from isolates of free-range chickens (Gallus gallus domesticus) circulating in the state of Paraíba, Northeast Brazil.

Authors:  Thais Ferreira Feitosa; Vinícius Longo Ribeiro Vilela; João Leite de Almeida-Neto; Lídio Ricardo Bezerra de Melo; Dayana Firmino de Morais; Bruna Farias Alves; Fabiana Nakashima; Solange Maria Gennari; Ana Célia Rodrigues Athayde; Hilda Fátima de Jesus Pena
Journal:  Parasitol Res       Date:  2017-06-21       Impact factor: 2.289

Review 3.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

4.  Genotype analysis of T. gondii strains associated with human infection in Egypt.

Authors:  Mona Mohamed Tolba; Hend Ali El-Taweel; Safia Saleh Khalil; Walaa Ali Hazzah; Mohamed Gamal Heshmat
Journal:  Parasitol Res       Date:  2014-02-14       Impact factor: 2.289

5.  Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Authors:  Florence Robert-Gangneux; Yvon Sterkers; Hélène Yera; Isabelle Accoceberry; Jean Menotti; Sophie Cassaing; Marie-Pierre Brenier-Pinchart; Christophe Hennequin; Laurence Delhaes; Julie Bonhomme; Isabelle Villena; Emeline Scherer; Frédéric Dalle; Feriel Touafek; Denis Filisetti; Emmanuelle Varlet-Marie; Hervé Pelloux; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

6.  Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.

Authors:  Ai Ying Teh; Atefeh Amerizadeh; Sabariah Osman; Muhammad Hafiznur Yunus; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2016-10-04       Impact factor: 2.894

7.  Maternal Anti-Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate.

Authors:  Hélène Guegan; Tijana Stajner; Branko Bobic; Cindy Press; Rares T Olariu; Kjerstie Olson; Jelena Srbljanovic; Jose G Montoya; Olgica Djurković-Djaković; Florence Robert-Gangneux
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

8.  Multiple intracerebral lesions in a young male.

Authors:  Madi Deepak; Achappa Basavaprabhu; Mahalingam Soundarya
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

9.  A conserved apicomplexan microneme protein contributes to Toxoplasma gondii invasion and virulence.

Authors:  My-Hang Huynh; Martin J Boulanger; Vern B Carruthers
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

10.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.